Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HESTIA: Dronedarone for Atrial Fibrillation Burden in Pacemaker Patients
NCT01135017Phase 4Terminated
- Sponsor
- Sanofi
- Start
- Jul 2010
- Primary completion
- Feb 2012
- Countries
- 1
01
Overview
A Phase 4 trial of dronedarone in Atrial fibrillation (AFib), sponsored by Sanofi. Started Jul 2010; status: terminated.
02
Drugs
dronedarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT01135017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01135017.